Bind Research
Our Research
Many incurable diseases involve biomolecules called ‘disordered proteins’ – considered ‘undruggable’ by the mainstream pharmaceutical industry.
These disordered proteins continuously change their three-dimensional shapes and lack long-lived sites with which drug-molecules can interact. Our mission is to make disordered proteins druggable. We are screening millions of disordered protein/drug-molecule pairs to learn the rules of drugging disordered proteins.
Our Expertise
Building on our expertise and working with academic and industrial partners, we are leveraging cutting-edge biology, engineering, and AI to deliver new drugs and tools.
We are building comprehensive datasets of disordered protein-drug interactions to create public assets to fuel AI models and accelerate the discovery process. To accomplish this in a manner for maximum societal benefit, we have established a Focused Research Organisation (FRO), a fully-independent not-for-profit entity dedicated to this goal.
Got an IDP target? We’d love to hear from you. Intrinsically disordered proteins are implicated in some of the most important and least-treated diseases in human health, but for a long time the tools to drug them simply didn’t exist. At Bind, we’re building those tools, and we want to put them to work on […]
19 Mar 2026
On 19 March 2026, Bind Research officially launched to an audience of more than 300 scientists, investors, policymakers, clinicians and technologists at One Triton Square, London. The event was hosted by VentureCafé London, sponsored by ARIA. The evening featured two keynote speakers. Professor Sheena Radford OBE FRS FMedSci spoke about why intrinsically disordered proteins remain […]
19 Mar 2026
30% of the human proteome is intrinsically disordered. Almost none of it is considered druggable. That is one of the largest unmet opportunities in medicine. Bind has recently published two papers setting out exactly why disordered proteins have resisted drug discovery for so long. The barriers are real: no stable binding pockets, no scalable measurement […]
18 Mar 2026
Do you have a background in a highly technical field and a passion for disordered proteins and drug discovery?
Interested in working with Bind to make disordered proteins druggable? Reach out!
Find out more
We are onboarding partners in charities, the pharmaceutical industry, technology, academia and more. Please reach out!
Find out more